 Samuel Gershon,
M.D., whose groundbreaking work on lithium helped pave
the way for the understanding of mood stabilizers, has
joined the Department of Psychiatry and Behavioral Sciences
at the Miller School as the vice chair for academic affairs.
A leading authority on the therapeutic use of lithium
in treating affective disorders and an internationally
recognized psychiatric expert, his research has influenced
the way bipolar disorder is treated throughout the world.
Former associate vice chancellor for research
in the health sciences and professor of psychiatry in
the Department
of Psychiatry at the University of Pittsburgh School
of Medicine, Gershon co-founded the journal Bipolar
Disorders and co-founded the International Society for Bipolar
Disorders. For
14 years he was a professor of psychiatry and directed
the
neuropsychopharmacology unit at New York University,
and he also served as chairman of psychiatry at Wayne
State
University and director of the Lafayette Clinic. He
has published more than 600 articles, book chapters,
and
two dozen books in psychiatric areas.
He received the Pfizer Researcher Prize
in 1959, the American Psychiatric Association’s Rush Gold Medal Award in
1970, the Taylor Manor Hospital Psychiatric Award in 1979,
and Wayne State University’s Gershenson Distinguished
Faculty Fellowship in 1986 |
